Coughlin Timothy Insider Trades

Insider Trading History

Track insider trading activity for Coughlin Timothy. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.19M 56,250 shares
Last Trade
Jun 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$501k 10,000 shares
$50.07
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $0 0 shares
Last Trade
Jun 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$520k 10,000 shares
$52.04
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.76M 66,250 shares
Last Trade
Jun 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$520k 10,000 shares
$52.04
$56.74
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $154k 16,000 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$272k 32,000 shares
$8.51
$9.61
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.19M 56,250 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$676k 16,000 shares
$42.26
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $2.96M 52,250 shares
Last Trade
May 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$141k 3,250 shares
$43.49
$56.74
Atyr Pharma
Atyr Pharma ATYR
Director
Holding Value $26.7k 50,000 shares
Last Trade
May 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.5k 50,000 shares
$0.95
$0.53
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.15M 55,500 shares
Last Trade
Oct 31, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$631k 18,000 shares
$35.03
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $0 0 shares
Last Trade
Oct 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$633k 18,000 shares
$35.16
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $4.17M 73,500 shares
Last Trade
Oct 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$633k 18,000 shares
$35.16
$56.74
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $102k 80,000 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$287k 80,000 shares
$3.59
$1.28
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.15M 55,500 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$412k 19,500 shares
$21.15
$56.74
Atyr Pharma
Atyr Pharma ATYR
Director
Holding Value $26.7k 50,000 shares
Last Trade
May 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 50,000 shares
$3.34
$0.53
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $120k 40,000 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 40,000 shares
$3.68
$2.99
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $1.02M 56,000 shares
Last Trade
May 30, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$87.5k 50,000 shares
$1.75
$18.30
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $439k 24,000 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.6k 24,000 shares
$1.86
$18.30
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $2.78M 49,000 shares
Last Trade
May 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 19,500 shares
$6.82
$56.74
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $120k 40,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 40,000 shares
$5.52
$2.99
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $2.41M 42,500 shares
Last Trade
May 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 13,500 shares
$17.11
$56.74
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $220k 12,000 shares
Last Trade
May 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.2k 12,000 shares
$2.52
$18.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up